In postmenopausal women, risk was associated with higher TZD dose.
绝经后女性骨折风险与服用大剂量tzd有关。
Treatments used in the control groups included placebo, usual care, and non-TZD antidiabetic therapies.
控制组的治疗方案包括安慰剂,常规护理和非噻唑啉二酮类药物抗糖尿病治疗。
The adjusted hazard ratios associated with TZD use were 1.0 for HF hospitalization and 0.98 for mortality.
应用TZDs的患者,心衰住院的调整危险比为1.0,心衰死亡率的调整危险比为0.98。
应用推荐